Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Yatsu

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Archives of Neurology|December 11, 1999
Is cholesterol a risk factor for stroke?: YesA M Demchuk, D C Hess, L M Brass, et al.
Neurology|February 1, 1988
Anticoagulation of embolic strokes of cardiac origin: an updateF M Yatsu, R G Hart, J P Mohr, et al.
Molecular and Cellular Biochemistry|May 23, 2000
Butyrate inhibits proliferation-induced proliferating cell nuclear antigen expression (PCNA) in rat vascular smooth muscle cellsK Ranganna, F M Yatsu, B E Hayes, et al.
Stroke|November 1, 1990
Molecular biology of atherothrombotic brain infarctionF M Yatsu, R Kasturi, R Alam, et al.
Neurology|November 1, 1984
Prostacyclin infusion in acute cerebral infarctionV T Miller, B M Coull, F M Yatsu, et al.
Archives of Internal Medicine|July 1, 1992
A critical appraisal of ticlopidine, a new antiplatelet agent. Effectiveness and clinical indications for prophylaxis of atherosclerotic eventsR B Haynes, R S Sandler, E B Larson, et al.
Atherosclerosis|March 1, 1984
Cholesteryl ester hydrolase activity in mononuclear cells from patients with type II hypercholesterolemiaF C Hagemenas, L C Manaugh, D R Illingworth, et al.
Stroke|September 1, 1985
Baseline hemodynamic state and response to hemodilution in patients with acute cerebral ischemiaJ C Grotta, L C Pettigrew, S Allen, et al.
Neurology|April 1, 1986
Thromboxane, prostacyclin, and leukotrienes in cerebral ischemiaS T Chen, C Y Hsu, E L Hogan, et al.
Stroke|March 1, 1986
Community Hospital-based Stroke Programs: North Carolina, Oregon, and New York. II: Description of study populationC Becker, G Howard, K R McLeroy, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Archives of Neurology|December 11, 1999
Is cholesterol a risk factor for stroke?: YesA M Demchuk, D C Hess, L M Brass, et al.
Neurology|February 1, 1988
Anticoagulation of embolic strokes of cardiac origin: an updateF M Yatsu, R G Hart, J P Mohr, et al.
Molecular and Cellular Biochemistry|May 23, 2000
Butyrate inhibits proliferation-induced proliferating cell nuclear antigen expression (PCNA) in rat vascular smooth muscle cellsK Ranganna, F M Yatsu, B E Hayes, et al.
Stroke|November 1, 1990
Molecular biology of atherothrombotic brain infarctionF M Yatsu, R Kasturi, R Alam, et al.
Neurology|November 1, 1984
Prostacyclin infusion in acute cerebral infarctionV T Miller, B M Coull, F M Yatsu, et al.
Archives of Internal Medicine|July 1, 1992
A critical appraisal of ticlopidine, a new antiplatelet agent. Effectiveness and clinical indications for prophylaxis of atherosclerotic eventsR B Haynes, R S Sandler, E B Larson, et al.
Atherosclerosis|March 1, 1984
Cholesteryl ester hydrolase activity in mononuclear cells from patients with type II hypercholesterolemiaF C Hagemenas, L C Manaugh, D R Illingworth, et al.
Stroke|September 1, 1985
Baseline hemodynamic state and response to hemodilution in patients with acute cerebral ischemiaJ C Grotta, L C Pettigrew, S Allen, et al.
Neurology|April 1, 1986
Thromboxane, prostacyclin, and leukotrienes in cerebral ischemiaS T Chen, C Y Hsu, E L Hogan, et al.
Stroke|March 1, 1986
Community Hospital-based Stroke Programs: North Carolina, Oregon, and New York. II: Description of study populationC Becker, G Howard, K R McLeroy, et al.
Pageof 7